Despite a century of credible cancer microbe research, the medical profession generally ignores all aspects of research implicating bacteria, viruses, fungus and other pathogens in cancer and certain chronic diseases (Heart disease, Osteoarthritis, among others).
Cancer and the Cancer Microbes
Although medical science claims the cause of most cancers is unknown, there is evidence accumulated since the late 19th century to show that cancer is a disease caused by infectious bacteria (not to be confused with viruses which are not visible microscopically). In 1890 the noted Scottish pathologist William Russell (1852-1940) discovered round forms in cancer tissue which he interpreted as "the characteristic organism of cancer." These forms were subsequently discredited as infectious agents but have become known to every pathologist as "Russell bodies." (For more details see, "The Russell Body: The forgotten clue to the bacterial cause of cancer")
The most vocal proponent of bacteria as a cause of cancer was the late Virginia Livingston, M.D. In 1950, Virginia Wuerthele-Caspe Livingston and Eleanor Alexander-Jackson (a microbiologist), along with John A Anderson (head of the Department of Bacteriology at Rutgers), James Hillier (head of the electron microscopy at the RCA Victor Laboratories at Princeton), Roy Allen (a renowned microscopist), and Lawrence W Smith (author of a well-known pathology textbook used in medical colleges), all combined their talents to write a paper entitled "Cultural Properties and Pathogenicity of Certain Microorganisms Obtained from Various Proliferative and Neoplastic Diseases," published in the December issue of The American Journal of the Medical Sciences. The characteristics of the cancer microbe in blood, tissue, and culture, were described in detail; and the extreme pleomorphic nature of the organism was revealed in photos taken with the electron microscope at a magnification of 31,000X. (The ordinary light microscope only magnifies a thousand times.)
The cancer microbe, which Livingston later called Progenitor cryptocides, was filterable through a pore designed to hold back bacteria, indicating that the smallest forms of the microbe were indeed "virus-sized." However, with time these filter-passing were able to grow and revert back to the size of conventional bacteria.
The microbe was characterized as pleomorphic that is, having more than one form and size. The smallest forms of the organism were virus-like, and the larger bacterial forms were comparable to what bacteriologists call "mycoplasma", "L-forms" and "cell-wall deficient forms." The largest forms of the organism resembled what Russell called "the cancer parasite." Livingston believed the organism was closely related to the mycobacteria, the species of acid-fast bacteria that causes tuberculosis. She claimed the "acid-fast" staining method was essential to identify the microbe in tissue and in culture.
In a series of papers Livingston and her colleagues all continued important cancer microbe research showing the characteristic "connective tissue parasite" of cancer, the germ that could be found inside the cell (intracellular) and outside the cell (extracellular) in all cancers they studied. Livingston always stressed that the microbe tends to involve the collagenous (connective) tissue, and the photographs presented here in prostate cancer confirm that.
When she died in 1990 at the age of 84, she was widely regarded as a quack, particularly by the American Cancer Society which claimed her cancer microbe did not exist. Likewise, a bulletin published by the National Cancer institute on Nov 30, 1990 stated: "There is no scientific evidence to confirm Livingston's theories of cancer causation."
More details covering a century of cancer microbe research can be found in the book, The Cancer Microbe: The Hidden Killer in Cancer, AIDS, and Other Immune Diseases (1990) , in Cell Wall Deficient Bacteria (1993) by Lida Mattman, Ph.D., in Can Bacteria Cause Cancer?: Alternative Medicine Confronts Big Science (1997) by David Hess, and also by initiating a computer search at www.google.com and typing in "cancer bacteria", "cancer microbe", or "cancer-associated bacteria."
Over the past four decades personal publications in medical journals record the presence of cancer bacteria in various cancers, including breast cancer, Kaposi's sarcoma, Hodgkin's disease, mycosis fungoides, as well as in non-cancerous diseases like scleroderma, lupus erythematosus, and sarcoidosis. Additional papers on the microbiology of cancer are presented online at the Journal of Independent Medical Research web site (www.joimr.org). References and abstracts on 10 cancer microbe medical publications can be found at the National Library of Medicine's "PubMed" web site. (Type in "Cantwell AR + cancer bacteria".]
According to Livingston, the cancer microbe is present in the blood, tissue, excreta, and body fluids of all human beings. When the immune system is functioning normally these microbes did not cause disease. However, when tissue is damaged or weakened these microbes became aggressive and pathogenic, producing hardening and thickening of the tissue (such as found in scleroderma and heart disease), inflammation (autoimmune diseases and sarcoidosis) and proliferative and cancerous changes. The cancer microbe is essential to our life biology. When conditions are adverse, it emerges and reverts to its pathogenic form.
Livingston's research is connected with newer microbiologic findings indicating that the blood of all human beings is infected with a variety of so-called "cell wall deficient" bacteria. Tiny, virus-like forms of the cancer microbes are undoubtedly related to the tiniest of newly-discovered bacteria currently called nanobacteria. These previously neglected and largely-unstudied nanobacteria, which lie in size between the normal-sized bacteria and the smallest viruses, are thought to be involved in a variety of skin and heart ailments presently labeled as diseases of unknown etiology. An excellent source of up-to-date nanobacteria research can be found at the Nanobac Pharmaceutical web site.
We at the Integrative Cancer Therapy Team have incorporated a combination of detoxification and antimicrobial therapies that will help the cancer patient fight and get rid of these out of controlled microbes. The detoxification therapy not only will allow the patient’s own immune system to recuperate but also be able to fight off these disease causing microbes. This combination therapy will give the patient a better chance to fight the cancer and allow the patient to reach a better prognosis.